Pfizer Selects ChemAxon's Markush Platform
BUDAPEST, Hungary, January 22 /PRNewswire/ --
- Pfizer Globally Licenses ChemAxon's Platform For Markush Structure Searching And Enumeration
ChemAxon - a leading provider of cheminformatics software for the life sciences industry has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.
"Markush structure search and enumeration is becoming of critical importance for structure IP and patent development." said Alex Drijver, CEO of ChemAxon. "It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront."
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.
SOURCE ChemAxon Ltd.